Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

LNTH

Lantheus (LNTH)

Lantheus Holdings Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:LNTH
DateTimeSourceHeadlineSymbolCompany
09/25/20243:44PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:LNTHLantheus Holdings Inc
09/15/20247:45AMGlobeNewswire Inc.Lantheus Presents Results from the Primary Analysis of Phase 3 Pivotal SPLASH Trial in PSMA-Positive Metastatic Castration-Resistant Prostate Cancer During ESMO Congress 2024NASDAQ:LNTHLantheus Holdings Inc
09/13/202412:29PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:LNTHLantheus Holdings Inc
09/05/20247:38AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:LNTHLantheus Holdings Inc
09/05/20247:30AMGlobeNewswire Inc.Lantheus Appoints Julie Eastland as New Board MemberNASDAQ:LNTHLantheus Holdings Inc
09/03/20243:30PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LNTHLantheus Holdings Inc
08/28/20247:30AMGlobeNewswire Inc.Lantheus to Present at the Morgan Stanley 22nd Annual Global Healthcare ConferenceNASDAQ:LNTHLantheus Holdings Inc
08/21/20243:35PMEdgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:LNTHLantheus Holdings Inc
08/20/20247:30AMGlobeNewswire Inc.Lantheus to Present Additional Clinical Data from Phase 3 Pivotal SPLASH Trial in PSMA-Positive Metastatic Castration-Resistant Prostate Cancer During ESMO Congress 2024NASDAQ:LNTHLantheus Holdings Inc
08/19/20243:30PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LNTHLantheus Holdings Inc
08/16/20243:30PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LNTHLantheus Holdings Inc
08/14/20243:56PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LNTHLantheus Holdings Inc
08/14/202411:41AMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:LNTHLantheus Holdings Inc
08/13/20249:59AMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:LNTHLantheus Holdings Inc
08/12/20244:09PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LNTHLantheus Holdings Inc
08/12/20244:04PMEdgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:LNTHLantheus Holdings Inc
08/12/20243:23PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:LNTHLantheus Holdings Inc
08/08/202410:16AMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:LNTHLantheus Holdings Inc
08/06/20243:30PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LNTHLantheus Holdings Inc
08/02/20243:21PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:LNTHLantheus Holdings Inc
07/31/20246:50AMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:LNTHLantheus Holdings Inc
07/31/20246:47AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:LNTHLantheus Holdings Inc
07/31/20246:00AMGlobeNewswire Inc.Lantheus Reports Second Quarter 2024 Financial ResultsNASDAQ:LNTHLantheus Holdings Inc
07/17/20243:32PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LNTHLantheus Holdings Inc
07/17/20243:30PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LNTHLantheus Holdings Inc
07/17/20247:30AMGlobeNewswire Inc.Lantheus to Host Second Quarter 2024 Earnings Conference Call and Webcast on July 31, 2024, at 8:00 a.m. Eastern TimeNASDAQ:LNTHLantheus Holdings Inc
07/16/20242:32PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:LNTHLantheus Holdings Inc
07/15/202411:20AMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:LNTHLantheus Holdings Inc
07/15/20247:30AMGlobeNewswire Inc.Lantheus Acquires NAV-4694, a Next-Generation ß Amyloid PET Imaging Agent for Alzheimer’s DiseaseNASDAQ:LNTHLantheus Holdings Inc
07/10/202411:32AMGlobeNewswire Inc.Lantheus Welcomes CMS’ Proposed CY25 Rule for Improved Payment for Specialized Diagnostic Radiopharmaceuticals to Support Patient AccessNASDAQ:LNTHLantheus Holdings Inc
 Showing the most relevant articles for your search:NASDAQ:LNTH

Your Recent History

Delayed Upgrade Clock